東北大学大学院医学系研究科 医科学専攻 病理病態学講座
病理診断学分野
Department of Anatomic Pathology
論文発表（英文）
2024年
左端の番号をクリックするとPubMedに移動します.
Watanabe H, Fujishima F, Unno M, Sasano H, Suzuki T.
Immunohistochemical and in situ hybridization analyses of glucose transporter 2 in pancreatic neuroendocrine tumors: Possible glucose transporter 2 association with neoplastic insulin production
Pathol Res Pract. 2024 Jan. 253:154966.
Ohkubo Y, Yamazaki M, Shimada Y, Kubota S, Takayama S, Oiwa A, Yamazaki Y, Sasano H, Komatsu M.
Rare Coexistence of Aldosterone-producing Adrenocortical Adenoma Confirmed by an Immunohistochemical Analysis of Steroidogenic Enzymes with Adrenal Ectopic Thyroid Tissue: A Case Report and Literature Review
Intern Med. 2024 Jan. 63(2):259-264.
Wang Y, Harada-Shoji N, Kitamura N, Yamazaki Y, Ebata A, Amari M, Watanabe M, Miyashita M, Tada H, Abe T, Suzuki T, Gonda K, Ishida T.
Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer
Cancer Med. 2024 Jan. 13(2):e6987.
Muroyama Y, Nagumo M, Fujishima F, Suzuki T.
Sea urchin granuloma - a chronic complication of sea urchin spine injuries.
QJM. 2024 Feb. 117(1):77-78.
Ohya Y, Ogiso Y, Matsuda M, Sakae H, Nishida K, Miki Y, Fox TE, Kester M, Sakamoto W, Nabe T, Kitatani K.
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer
Cell Cells. 2024 Feb. 13(5):405.
Honma S, Sato N, Sakaguchi R, Hashiguchi A, Uesugi N, Nakamura Y, Sasano H, Joh K.
Morphological and etiological analyses of C3 and non-C3 glomerulonephritis in primary membranoproliferative glomerulonephritis using periodic acid-methenamine silver stain electron microscopy: a retrospective multicentered study
Med Mol Morphol. 2024 Mar. 57(1):23-34.
Wittayavimol N, Iwabuchi E, Pateetin P, Miki Y, Onodera Y, Sasano H, Boonyaratanakornkit V.
Progesterone receptor-Grb2 interaction is associated with better outcomes in breast cancer
J Steroid Biochem Mol Biol. 2024 Mar. 237:106441
Nanba K, Blinder AR, Udager AM, Hirokawa Y, Miura T, Okuno H, Moriyoshi K, Yamazaki Y, Sasano H, Yasoda A, Satoh-Asahara N, Rainey WE, Tagami T.
Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma
Front Endocrinol (Lausanne). 2024 Mar. 5;15:1286297.
Kimura N, Tsukita Y, Ebina-Shibuya R, Miyauchi E, Yamada M, Narita D, Saito R, Inoue C, Fujino N, Ichikawa T, Tamada T, Sugiura H.
Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC
Cancer Biomark. 2024 Mar. Online ahead of print
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Harada-Shoji N, Suzuki T, Nakanishi M, Ohta T, Ishida T.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma
Breast Cancer Res Treat. 2024 Apr. 204(3):453-463.
Ishikawa Y, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Tokodai K, Fujishima F, Kawanabe S, Katabami T, Ikeya A, Yamashita M, Oki Y, Nanjo H, Satoh F, Ito A, Unno M, Kamei T, Sasano H, Suzuki T.
Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity
J Steroid Biochem Mol Biol. 2024 Apr. 238:106462
Ono Y, Tezuka Y, Omata K, Morimoto R, Yamazaki Y, Oguro S, Takase K, Ito A, Yoshimi T, Kojima S, Ito S, Sasano H, Suzuki T, Tanaka T, Katagiri H, Satoh F.
Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA
J Endocr Soc. 2024 Apr. 8(6):bvae080.
Taguchi R, Yamaguchi-Tanaka M, Takagi K, Sato A, Miki Y, Miyashita M, Suzuki T.
Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer
Acta Histochem Cytochem. 2024 Apr. 57(2):75-83.
Saito-Koyama R, Tamai K, Yasuda J, Okamura Y, Yamazaki Y, Inoue C, Miki Y, Abe J, Oishi H, Sato I, Sasano H.
Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma
Virchows Arch. 2024 Apr. 484(4):609-620.
Inoue C, Amata A, Chonan T, Kawabata Y, Matsuno Y, Suzuki T.
Paraseptal Emphysema in Indium Lung: Tracing the Pathological Footprints of Chronic Exposure
Tohoku J Exp Med. 2024 May. 263(1):51-54.
Tezuka Y, Omata K, Ono Y, Kambara K, Kamada H, Oguro S, Yamazaki Y, Gomez-Sanchez CE, Ito A, Sasano H, Takase K, Tanaka T, Katagiri H, Satoh F.
Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study
Hypertens Res. 2024 May. 47(5):1362-1371.
Santen RJ, Karaguzel G, Livaoglu M, Yue W, Cline JM, Ratan A, Sasano H.
Role of ERα and Aromatase in Juvenile Gigantomastia
J Clin Endocrinol Metab. 2024 Jun. 109(7):1765-1772.
Uchihara M, Tanabe A, Kojima Y, Shimoi T, Maeshima AM, Umamoto K, Shimomura A, Shimizu C, Yamazaki Y, Nakamura E, Matsui Y, Takemura N, Miyazaki H, Sudo K, Yonemori K, Kajio H.
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma
Cancers (Basel). 2024 Jun. 16(12):2191.
Mulders MCF, van Velthuysen MLF, Roes EM, Hofland LJ, Sasano H, de Herder WW, Hofland J.
Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients
Eur J Endocrinol. 2024 Jul. 191(1):K1-K4.
Hayasaka K, Fujita T, Eba S, Sato N, Kurotaki H, Inoue C.
Pulmonary Alveolar Proteinosis-Like Pathological Changes Mimicking Lung Adenocarcinoma in Situ
Tohoku J Exp Med. 2024 Jul. Online ahead of print.
Sugawara H, Wada N, Baba S, Miyoshi A, Obara S, Yamazaki Y, Sasano H.
A case of Cushing's syndrome in a pregnant woman associated with hypertension, hypokalemia, and gestational diabetes mellitus
Diabetol Int. 2024 Jul. 15(4):845-849.
Takahashi I, Takagi K, Yamaguchi-Tanaka M, Sato A, Sato M, Miki Y, Ito A, Suzuki T.
Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasion
Pathol Res Pract 2024 Aug. 260:155379.
Inoue C, Miki Y, Saito-Koyama R, Okada Y, Sasano H, Suzuki T.
Dipeptidyl peptidase 4-positive cancer-associated fibroblasts enhance lung adenocarcinoma growth
Pathol Res Pract. 2024 Aug. 260:155418.
Fujisawa S, Takagi K, Yamaguchi-Tanaka M, Sato A, Miki Y, Miyashita M, Tada H, Ishida T, Suzuki T.
Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer
Pathol Res Pract. 2024 Aug. 260:155434
Takayama KI, Suzuki T, Sato K, Saito Y, Inoue S.
Cooperative nuclear action of RNA-binding proteins PSF and G3BP2 to sustain neuronal cell viability is decreased in aging and dementia
Aging Cell. 2024 Aug. e14316
Yamazaki A, Tada H, Muroyama Y, Yamazaki Y, Miyashita M, Harada-Shoji N, Hamanaka Y, Ebata A, Sato M, Motonari T, Yanagaki M, Kon T, Sakamoto A, Suzuki T, Ishida T.
Surgical and irradiated case of early breast cancer in a patient with Ehlers-Danlos syndrome
Surg Case Rep. 2024 Aug. 10(1):195.
Miki Y, Iwabuchi E, Inoue C, Yamazaki Y, Suzuki T.
Histopathological analysis potential for unveiling hormone signaling in endocrine-related tumors
Endocr Oncol. 2024 Aug. 4(1):e240033.
Muroyama Y, Miura C, Imai Y, Suzuki T.
Ossification of neurofibroma in neurofibromatosis type 1, a case report of a rare presentation
Int J Surg Case Rep. 2024 Sep. 122:110151.
Muroyama Y, Yanagaki M, Ebata A, Yamazaki Y, Ishida T, Suzuki T.
Anemia and giant breast mass
J Am Coll Emerg Physicians Open 2024 Sep. 5(5):e13298.
Duangthim N, Lomphithak T, Saito-Koyama R, Miki Y, Inoue C, Sato I, Miyauchi E, Abe J, Sasano H, Jitkaew S.
Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer
Sci Rep. 2024 Sep. 14(1):21625.
Takeuchi K, Suzuki H, Takanami K, Ota H, Tanaka Y, Fujishima F, Watanabe H, Susukita K, Inoue T, Arai M, Hayashi H, Nochioka K, Takahama H, Suzuki T, Takase K, Yasuda S.
Reduced 18F-FDG uptake in the basal interventricular septum as a predictor of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis
Int J Cardiol. 2024 Oct. 132686
Fujisawa S, Takagi K, Yamaguchi-Tanaka M, Sato A, Miki Y, Miyashita M, Tada H, Ishida T, Suzuki T.
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance
Cancers (Basel). 2024 Oct. 16(21):3600.
Iwabuchi E, Miki Y, Xu J, Kanai A, Ishida T, Sasano H, Suzuki T.
Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer
Int J Exp Pathol. 2024 Oct.
Shironomae T, Yamazaki Y, Takeyama J, Sakai K, Sasano H, Suzuki T.
Development of aldosterone biosynthesis during fetal and pediatric periods; Histological analysis of CYP11B2-positive cell distribution in the zona glomerulosa of human adrenal
J Steroid Biochem Mol Biol. 2024 Nov. 244:106593.
Watanabe H, Enda K, Fujishima F, Shirota H, Ninomiya M, Yamazaki T, Sasano H, Suzuki T.
Primary hepatic alpha-fetoprotein-producing neuroendocrine neoplasm harboring FGFR2 and TP53 mutations: a case report and literature review
Med Mol Morphol. 2024 Nov. Online ahead of print.
Yamazaki Y, Tezuka Y, Ono Y, Satoh F, Sasano H, Suzuki T.
Updates on WHO 5th edition classification, molecular characteristics and tumor microenvironment of adrenocortical carcinomas
Endocr J. 2024 Nov. Online ahead of print.
2023年
左端の番号をクリックするとPubMedに移動します.
Numasaki M, Ito K, Takagi K, Nagashima K, Notsuda H, Ogino H, Ando R, Tomioka Y, Suzuki T, Okada Y, Nishioka Y, Unno M.
Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8
Cell Immunol. 2023 Jan. 383:104652.
Miki Y, Iwabuchi E, Suzuki T.
In Situ Proximity Ligation Assay to Visualize Protein-Protein Interactions in Tumor Specimens
Methods Mol Biol. 2023 2660:123-135.
Inoue C, Ohkouchi S, Chonan T, Amata A, Hirama T, Saito-Koyama R, Kawabata Y, Suzuki T, Okada Y, Tanaka A, Kurosawa H.
A case report of Indium lung with progressive emphysema and fibrosis underwent lung unilateral transplantation 20 years after the end of the exposure
Diagn Pathol. 2023 Jan 18(1):10.
Yamamoto T, Kimura T, Kubo Y, Nakatsuka SI, Harada H, Suzuki T, Sasano H.
An adrenal incidentaloma that had appeared to produce dehydroepiandrosterone-sulfate in excess before immunohistochemical study of the tumor
Endocr J. 2023 Jan. 70(1):43-46.
Yamaguchi-Tanaka M, Takagi K, Miki Y, Sato A, Iwabuchi E, Miyashita M, Suzuki T.
The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages
Cancers (Basel). 2023 Mar. 22;15(6):1903.
Watanabe H, Fujishima F, Unno M, Sasano H, Suzuki T.
Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells
Pathol Res Pract. 2023 Apr. 244:154418.
Sato A, Takagi K, Yoshimura A, Tsukamoto W, Yamaguchi-Tanaka M, Miki Y, Ebata A, Miyashita M, Suzuki T.
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
Int J Mol Sci. 2023 May 24(9):8419.
Inoue C, Miki Y, Suzuki T.
New Perspectives on Sex Steroid Hormones Signaling in Cancer-Associated Fibroblasts of Non-Small Cell Lung Cancer.
Cancers (Basel) 2023 Jul. 15(14): 3620
Zhang J, Miki Y, Iwabuchi E, Xu J, Kanai A, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, Ishida T, Suzuki T, Sasano H.
Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
Breast Cancer Res Treat. 2023 Aug. 200(3):323-335.
Ebata A, Suzuki T, Shoji-Harada N, Hamanaka Y, Miyashita M, Iwabuchi E, Takagi K, Miki Y, Tada H, Ishida T.
Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor.
Acta Histochem Cytochem. 2023 Aug. 56(4):59-66.
Khalid F, Takagi K, Sato A, Yamaguchi M, Guestini F, Miki Y, Miyashita M, Hirakawa H, Ohi Y, Rai Y, Sagara Y, Sasano H, Suzuki T.
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration.
Breast Cancer. 2023 Sep. 30(5):748-757.
Tsunokake S, Iwabuchi E, Miki Y, Kanai A, Onodera Y, Sasano H, Ishida T, Suzuki T.
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast.
Breast Cancer Res Treat. 2023 Oct. 201(3):499-513.
Miki Y, Iwabuchi E, Takagi K, Yamazaki Y, Shibuya Y, Tokunaga H, Shimada M, Suzuki T, Ito K.
Intratumoral cortisol associated with aromatase in the endometrial cancer microenvironment.
Pathol Res Pract. 2023 Nov. 251:154873.
Muroyama Y, Inoue C, Fujishima F, Shigeta S, Hasegawa-Minato J, Shimada M, Suzuki T.
ExcLAMation marks in a pelvic lymph node
Clin Case Rep. 2023 Dec. 11(12):e8339.
Suzuki S, Takahashi N, Sugo M, Ishiwata K, Ishida A, Watanabe S, Igarashi K, Ruike Y, Naito K, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Kubota Y, Wada T, Yamazaki Y, Sasano H, Ikeda JI, Tatsuno I, Yokote K.
Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literature
BMC Endocr Disord. 2023 Dec. 23(1):276.
Kitamoto T, Idé T, Tezuka Y, Wada N, Shibayama Y, Tsurutani Y, Takiguchi T, Inoue K, Suematsu S, Omata K, Ono Y, Morimoto R, Yamazaki Y, Saito J, Sasano H, Satoh F, Nishikawa T.
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study
Sci Rep. 2023 Dec. 13(1):21722.
Notsuda H, Tomiyama F, Onodera K, Watanabe T, Watanabe Y, Oishi H, Niikawa H, Inoue C, Ota H, Noda M, Okada Y.
Systemic-to-pulmonary artery shunt treated with transcatheter arterial embolization and subsequent lung segmentectomy
Egypt Heart J. 2023 Dec. 75(1):103.
2022年
左端の番号をクリックするとPubMedに移動します.
Sato T, Takagi K, Higuchi M, Abe H, Kojimahara M, Sagawa M, Tanaki M, Miki Y, Suzuki T, Hojo H.Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic FactorActa Histochem Cytochem2022Feb 55(1):25-35.
Miki Y, Iwabuchi E, Takagi K, Suzuki T, Sasano H, Yaegashi N, Ito K.Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer
Pathol Res Pract. 2022 Mar 231:153795.
Xu J, Iwabuchi E, Miki Y, Kanai A, Takagi K, Suzuki T, Ishida T, Sasano H.
FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer
Pathol Res Pract. 2022 Jun 234:153898.
Takeiwa T, Ikeda K, Suzuki T, Sato W, Iino K, Mitobe Y, Kawabata H, Horie K, Inoue S.
PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2
Sci Rep. 2022Jun12(1):9495.
Takagi K, Yamaguchi M, Miyashita M, Sasano H, Suzuki T.
Diverse role of androgen action in human breast cancer
Endocr Oncol. 2022 Aug 2(1):R102-R111.
Nishimura T, Takadate T, Maeda S, Suzuki T, Minowa T, Fukuda T, Bando Y, Unno M.
Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma
Sci Rep. 2022Aug12(1):14709.
Yamaguchi M, Sasaki T, Uemura K, Tajima Y, Kato S, Takagi K, Yamazaki Y, Saito-Koyama R, Inoue C, Kawaguchi K, Soma T, Miyata T, Suzuki T.
Automatic breast carcinoma detection in histopathological micrographs based on Single Shot Multibox Detector
J Pathol Inform. 2022 Sep13:100147.
Sato N, Motoi F, Tajiki H, Kawaguchi K, Ohtsuka H, Takadate T, Nakagawa K, Takagi K, Suzuki T, Katayose Y, Fukudo S, Unno M.
Expression of Corticotropin-Releasing Hormone and Its Receptors May Be Associated With Survival Rate in Pancreatic Cancer
Gastro Hep Adv. 2022 Sep2(1):147-155.
Iwabuchi E, Miki Y, Suzuki T, Sasano H.
Visualization of the protein-protein interactions of hormone receptors in hormone-dependent cancer research
Endocr Oncol. 2022 Oct2(1):R132-R142.
Shimada H, Hata S, Yamazaki Y, Otsubo Y, Sato I, Ise K, Yokoyama A, Suzuki T, Sasano H, Sugawara A, Nakamura Y.YM750, an ACAT Inhibitor, Acts on Adrenocortical Cells to Inhibit Aldosterone Secretion Due to Depolarization
Int J Mol Sci. 2022 Oct23(21):12803.
Horie K, Takagi K, Takeiwa T, Mitobe Y, Kawabata H, Suzuki T, Ikeda K, Inoue S.
Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
Cells. 2022 Nov11(22):3610.